about
Characteristics of frequent emergency department presenters to an Australian emergency medicine networkCloning and activity of a novel α-latrotoxin from red-back spider venomArachnid toxinology in Australia: from clinical toxicology to potential applicationsEvidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoning."Punk" rock can be bad for you: a case of surgical emphysema from a "punk" rocker's leather jacket.Treatments for Latrodectism-A Systematic Review on Their Clinical Effectiveness.Deliberate self-poisoning presenting to an emergency medicine network in South-East melbourne: a descriptive study.Red-back spider (Latrodectus hasselti) antivenom prevents the toxicity of widow spider venoms.Spiders of medical importance in the Asia-Pacific: atracotoxin, latrotoxin and related spider neurotoxins.Cross-reactivity of Sydney funnel-web spider antivenom: neutralization of the in vitro toxicity of other Australian funnel-web (Atrax and Hadronyche) spider venoms.A retrospective descriptive study of the characteristics of deliberate self-poisoning patients with single or repeat presentations to an Australian emergency medicine network in a one year period.Efficacy of Australian red-back spider (Latrodectus hasselti) antivenom in the treatment of clinical envenomation by the cupboard spider Steatoda capensis (Theridiidae).Calcium channel antagonist and beta-blocker overdose: antidotes and adjunct therapies.An in vitro analysis of the effects of intravenous lipid emulsion on free and total local anaesthetic concentrations in human blood and plasma.Treatment of the serotonin syndrome with cyproheptadine.Systematic review of the effect of intravenous lipid emulsion therapy for non-local anesthetics toxicity.Comparative hemodynamic effects of levosimendan alone and in conjunction with 4-aminopyridine or calcium chloride in a rodent model of severe verapamil poisoning.Neuroleptic malignant syndrome developing after acute overdose with olanzapine and chlorpromazine.Acetaminophen protein adduct formation following low-dose acetaminophen exposure: comparison of immediate-release vs extended-release formulations.Management of cardiac arrest following poisoning.Characteristics of paediatric frequent presenters to an Australian emergency medicine network.Paracetamol toxicity: what would be the implications of a change in Australian treatment guidelines?Methodology for AACT evidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoning.Off-label and unlicenced medicine administration to paediatric emergency department patients.Intrathecal Clonidine Pump Failure Causing Acute Withdrawal Syndrome With 'Stress-Induced' Cardiomyopathy.Management of mental health patients in Victorian emergency departments: A 10 year follow-up study.Adolescent deliberate self-poisoning in South-East Melbourne.A randomised controlled trial of paracetamol and ibuprofen with or without codeine or oxycodone as initial analgesia for adults with moderate pain from limb injury.Oxycodone/naloxone preparation can cause acute withdrawal symptoms when misused parenterally or taken orally.The PICHFORK (Pain in Children Fentanyl or Ketamine) trial: a randomized controlled trial comparing intranasal ketamine and fentanyl for the relief of moderate to severe pain in children with limb injuries.The PICHFORK (Pain InCHildren Fentanyl OR Ketamine) trial comparing the efficacy of intranasal ketamine and fentanyl in the relief of moderate to severe pain in children with limb injuries: study protocol for a randomized controlled trial.Risk prediction of hepatotoxicity in paracetamol poisoning.The effects of fructose-1,6-diphosphate on haemodynamic parameters and survival in a rodent model of propranolol and verapamil poisoning.Outcome at 30 days for low-risk chest pain patients assessed using an accelerated diagnostic pathway in the emergency department.Characteristics of Aboriginal and Torres Strait Islander presentations to three Victorian emergency departments.Simplification of the standard three-bag intravenous acetylcysteine regimen for paracetamol poisoning results in a lower incidence of adverse drug reactions.Sub-dissociative dose intranasal ketamine for limb injury pain in children in the emergency department: a pilot study.Levosimendan does not improve cardiac output or blood pressure in a rodent model of propranolol toxicity when administered using various dosing regimens.Levosimendan infusion improves cardiac output but not blood pressure in a rodent model of severe metoprolol toxicity.Fluoxetine-induced cardiotoxicity with response to bicarbonate therapy.
P50
Q24601472-2E1A4555-62B2-49CF-82AC-1A9F19410759Q28250533-C04F9B56-1637-4B7B-9A7E-9A36F7F9475DQ28260231-62620E02-8627-46CA-A6AC-ED0BB7B7500AQ30392678-2982FF65-4F08-4A7F-92EE-1AA23D6E054AQ30541892-B5CCED54-AC50-4023-8BA7-1DC71D2F8933Q33612097-23580B48-1273-4536-810C-2933E7E17456Q33849995-41495A89-93B1-4B9A-8267-F3297A18B934Q33933140-C15E8DC4-8173-4E87-959B-1F6ACEA31174Q33960668-D16AB896-2F46-4139-90C7-A9242C5DEFA0Q34102073-EDC96F4C-C93D-44AD-AF24-2D54639A88B9Q34212483-B199831F-3C81-4FEE-A9D1-7679ECDED545Q34421076-74879A5F-9633-48ED-B748-E9030812A54CQ34492811-77AD83E7-7FA1-451D-A2F3-DFA76069AC95Q34539883-A14BC8EF-2324-4BCF-9A5A-CB0D29617B73Q34750304-EA60B92B-1548-4316-B3BE-6E1A33352210Q35916822-A6456F71-BCCC-4FFE-BB51-86358C6C1C14Q36549063-F602B34A-43E7-47D4-9BFE-0375DF136CEAQ36549240-3DA8DBAA-472D-4AD6-83E0-ECDB5B6477FFQ36759456-415AEF6F-F76B-4C4C-9C14-FF5EFF79EF92Q37834087-65E8D192-001C-4174-BCA1-EE636FCE9C23Q38115820-4B9E9DCA-5FBE-4AEB-A5EF-6EEFC726B90EQ38202678-98A9BB4B-CC04-4B5B-8A14-DE327D14B98BQ38522853-5113341D-0F2E-4EDE-AFC6-DA0A7DDDAF74Q38536275-8746A106-B77E-4063-9392-48CA47447770Q38829873-9FD35E13-E286-486D-A7A1-F5FEBB0AE987Q38939425-DC3C9ADC-1F64-4B10-B48C-2923A17A0609Q38970748-11D36815-0AF0-4F7A-9D44-268218764A74Q39167694-3730134B-0E82-4E09-8371-56696FD137ABQ39187409-30761ED9-BDB9-4A85-9895-AFCCB775CCC8Q39197890-2F86A91B-8A97-43B1-B0E1-07B83ED8CEE2Q39224124-B51542E5-CC71-4F13-8A2F-CA696B1B302DQ39266595-9DFB93BA-AA7D-4A76-9263-3F2A2D4EC2F5Q39573134-71DEAD53-D686-4732-8C0F-F259CFFB6FEFQ39902208-3C529AF5-C6FD-4622-9F59-208423723F51Q40155619-6286AD15-E63D-486D-9E4F-7F607DDD5102Q41106436-9B5152BE-6B7F-412B-917E-0D2C9850A36DQ41970269-C5CE7EAD-730C-4C6F-9AD6-D3E099BB9944Q41976777-BBDBAE58-FFD2-44E0-9A51-D9CD210EC7D5Q41977862-659281CB-F8A6-47F0-B5AC-6EDA11916270Q42055775-2994AB14-1291-4DD6-80C6-CD4F296F5554
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Andis Graudins
@ast
Andis Graudins
@en
Andis Graudins
@es
Andis Graudins
@nl
type
label
Andis Graudins
@ast
Andis Graudins
@en
Andis Graudins
@es
Andis Graudins
@nl
prefLabel
Andis Graudins
@ast
Andis Graudins
@en
Andis Graudins
@es
Andis Graudins
@nl
P106
P1153
55790181600
P21
P31
P496
0000-0002-0310-3983